Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens

Immunology

Volumn 142, Issue 1, 2014, Pages 140-150

  White, Matthew J ^a   Nielsen, Carolyn M ^a   Mcgregor, Reuben H C ^a   Riley, Eleanor M ^a   Goodier, Martin R ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

CD57; Diphtheria tetanus pertussis vaccine; Natural killer cells

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TOXOID; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR ALPHA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PERTUSSIS VACCINE; TETANUS TOXOID;

ADAPTIVE IMMUNITY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; NATURAL KILLER CELL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VACCINATION;

ADAPTIVE IMMUNITY; ADULT; AGED; ANTIGENS, BACTERIAL; ANTIGENS, CD56; ANTIGENS, CD57; BIOLOGICAL MARKERS; CELLS, CULTURED; DIPHTHERIA TOXOID; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; GPI-LINKED PROTEINS; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MIDDLE AGED; PERTUSSIS VACCINE; PHENOTYPE; RECEPTORS, IGG; RECEPTORS, INTERLEUKIN-12; TETANUS TOXOID; YOUNG ADULT;

EID: 84897998839     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12239     Document Type: Article

References (36)

1. Min-Oo G, Kamimura Y, Hendricks DW, Nabekura T, Lanier LL. Natural killer cells: walking three paths down memory lane. Trends Immunol 2013; 34:251-8.
2. + T cells are required for NK cell activation in vivo upon Leishmania major infection. J Immunol 2010; 185:2174-81.
3. + T cell-dependent activation of NK cells following vaccination. J Immunol 2010; 185:2808-18.
4. Horowitz A, Newman KC, Evans JH, Korbel DS, Davis DM, Riley EM. Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes. J Immunol 2010; 184:6043-52.
5. McCall MB, Roestenberg M, Ploemen I et al. Memory-like IFN-γ response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum. Eur J Immunol 2010; 40:3472-7.
6. Mandelboim O, Malik P, Davis DM, Jo CH, Boyson JE, Strominger JL. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc Natl Acad Sci U S A 1999; 96:5640-4.
7. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002; 296:1323-6.
8. Le Garff-Tavernier M, Beziat V, Decocq J et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 2010; 9:527-35.
9. Nielsen CM, White MJ, Goodier MR, Riley EM. Functional significance of CD57 expression on human NK cells and relevance to disease. Front Immunol 2013; 4:1-8.
10. dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010; 116:3853-64.
11. + NK cells: a functional intermediate stage of NK cell differentiation. J Immunol 2011; 186:6753-61.
12. + NK-cell subset. Blood 2010; 116:3865-74.
13. Newman KC, Riley EM. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol 2007; 7:279-91.
14. Horowitz A, Stegmann KA, Riley EM. Activation of natural killer cells during microbial infections. Front Immunol 2011; 2:88.
15. Korbel DS, Newman KC, Almeida CR, Davis DM, Riley EM. Heterogeneous human NK cell responses to Plasmodium falciparum-infected erythrocytes. J Immunol 2005; 175:7466-73.
16. Fransen F, Stenger RM, Poelen MC et al. Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis. PLoS ONE 2010; 5:e15692.
17. Horowitz A, Hafalla JC, King E et al. Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS, S/AS01 malaria vaccine. J Immunol 2012; 188:5054-62.
18. Evans JH, Horowitz A, Mehrabi M, Wise EL, Pease JE, Riley EM, Davis DM. A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG. Eur J Immunol 2011; 41:1924-33.
19. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19:197-223.
20. Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G, Fulop T. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol 2012; 24:331-41.
21. dim NK cells. Blood 2010; 116:1299-307.
22. Masopust D, Picker LJ. Hidden memories: frontline memory T cells and early pathogen interception. J Immunol 2012; 188:5811-7.
23. Nepom GT. MHC class II tetramers. J Immunol 2012; 188:2477-82.
24. Sivori S, Falco M, Della Chiesa M, Carlomagno S, Vitale M, Moretta L, Moretta A. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci U S A 2004; 101:10116-21.
25. Son YI, Dallal RM, Mailliard RB, Egawa S, Jonak ZL, Lotze MT. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-γ production, and expansion of natural killer cells. Cancer Res 2001; 61:884-8.
26. Fehniger TA, Shah MH, Turner MJ et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 1999; 162:4511-20.
27. Wang KS, Frank DA, Ritz J. Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood 2000; 95:3183-90.
28. Grubeck-Loebenstein B, Wick G. The aging of the immune system. Adv Immunol 2002; 80:243-84.
29. Hazeldine J, Lord JM. The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev. 2013; 12:1069-78.
30. Blackman MA, Woodland DL. The narrowing of the CD8 T cell repertoire in old age. Curr Opin Immunol 2011; 23:537-42.
31. Lambert ND, Ovsyannikova IG, Pankratz VS, Jacobson RM, Poland GA. Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach. Expert Rev Vaccines 2012; 11:985-94.
32. +) lymphocytes in relation to cytomegalovirus carrier status. Clin Exp Immunol 1988; 74:190-5.
33. hi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A 2011; 108:14725-32.
34. + natural killer cells with potent function. Blood 2012; 119:2665-74.
35. + NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J Immunol 2012; 189:5082-8.
36. Solana R, Tarazona R, Aiello AE et al. CMV and Immunosenescence: from basics to clinics. Immun Ageing 2012; 9:23.